227 results on '"Windsor, Joseph"'
Search Results
2. The contrastive hierarchy in phonology (review)
3. Global Hospitalization Trends for Crohn’s Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses
4. MODELING THE TRANSITION TO THE FOURTH EPIDEMIOLOGIC STAGE OF INFLAMMATORY BOWEL DISEASE: PREVALENCE EQUILIBRIUM
5. The Global Evolution of Inflammatory Bowel Disease across Four Epidemiologic Stages
6. The four epidemiological stages in the global evolution of inflammatory bowel disease
7. Bivalent mRNA SARS-CoV-2 vaccination in patients with inflammatory bowel disease
8. Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development
9. S1099 Comparison of Serological Responses to SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease Between Smokers and Non-Smokers
10. S1100 Associations Between Body Mass Index and Serological Responses to SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease
11. S1098 Serological Responses to SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease Are Impaired for Those on Anti-TNF and Immunomodulator Combination Therapy
12. The 2023 Impact of Inflammatory Bowel Disease in Canada: Treatment Landscape
13. The 2023 Impact of Inflammatory Bowel Disease in Canada: COVID-19 and IBD
14. The 2023 Impact of Inflammatory Bowel Disease in Canada: The Influence of Sex and Gender on Canadians Living With Inflammatory Bowel Disease
15. The 2023 Impact of Inflammatory Bowel Disease in Canada: Special Populations—Children and Adolescents with IBD
16. The 2023 Impact of Inflammatory Bowel Disease in Canada: Special Populations—IBD in Seniors
17. The 2023 Impact of Inflammatory Bowel Disease in Canada: Access to and Models of Care
18. The 2023 Impact of Inflammatory Bowel Disease in Canada: Cancer and IBD
19. The 2023 Impact of Inflammatory Bowel Disease in Canada: Indirect (Individual and Societal) and Direct Out-of-Pocket Costs
20. The 2023 Impact of Inflammatory Bowel Disease in Canada: Epidemiology of IBD
21. The 2023 Impact of Inflammatory Bowel Disease in Canada: Direct Health System and Medication Costs
22. The 2023 Impact of Inflammatory Bowel Disease in Canada: Mental Health and Inflammatory Bowel Disease
23. Commentary on the Epidemiology of Inflammatory Bowel Disease in Compounding Prevalence Nations: Toward Sustaining Healthcare Delivery
24. Association Between Celiac Disease and Autism Spectrum Disorder: A Systematic Review
25. The 2023 Impact of Inflammatory Bowel Disease in Canada: Executive Summary
26. Adverse Events & Serological Responses Following SARS-CoV-2 Vaccination in Individuals with Inflammatory Bowel Disease
27. Evolving Epidemiology of IBD
28. Adverse Events and Serological Responses After SARS-CoV-2 Vaccination in Individuals With Inflammatory Bowel Disease.
29. Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease
30. 2023 Impact of Inflammatory Bowel Disease in Canada
31. S1004 Adverse Events and Serological Responses Following SARS-CoV-2 Vaccination in Individuals With Inflammatory Bowel Disease
32. The WTO Committee on Trade in Financial Services: The Exercise of Public Authority within an Informational Forum
33. Global Hospitalization Trends for Crohn’s Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses
34. The Global Incidence of Peptic Ulcer Disease Is Decreasing Since the Turn of the 21st Century: A Study of the Organisation for Economic Co-Operation and Development (OECD)
35. Serological responses to three doses of SARS-CoV-2 vaccination in inflammatory bowel disease
36. 654: A THIRD DOSE OF SARS-COV-2 VACCINE YIELDS HIGH ANTIBODY LEVELS COMPARED TO TWO DOSE VACCINATION SCHEDULE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
37. Sa1556: GLOBAL HOSPITALIZATION TRENDS FOR FLARING CROHN'S DISEASE AND ULCERATIVE COLITIS: SYSTEMATIC REVIEW WITH TEMPORAL ANALYSES
38. Su1484: SEROLOGICAL RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY
39. Serological Responses to the First Three Doses of SARS-CoV-2 Vaccination in Inflammatory Bowel Disease: A Prospective Cohort Study
40. GLOBAL HOSPITALIZATION TRENDS FOR CROHN’S DISEASE AND ULCERATIVE COLITIS: SYSTEMATIC REVIEW WITH TEMPORAL ANALYSES
41. SEROLOGICAL RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY
42. GEOGRAPHIC DIFFERENCES IN THE RISK OF SURGERY IN INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
43. The four epidemiological stages in the global evolution of inflammatory bowel disease
44. Global Incidence of Acute Pancreatitis Is Increasing Over Time: A Systematic Review and Meta-Analysis
45. Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Children and Expectant Mothers With Inflammatory Bowel Disease
46. Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of Life
47. Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: COVID-19 Vaccines—Biology, Current Evidence and Recommendations
48. Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Executive Summary
49. Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Epidemiology—The Trends of Disease Over Time
50. Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Risk Factors and Medications
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.